Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease

NCT02958930 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Alzheimer Disease, Late Onset

Interventions

DEVICE: MemorEM 1000

Sponsor

NeuroEM Therapeutics, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]